Business World

Virus drives patients to virtual doctors and buoys telemedici­ne

-

THE new coronaviru­s that’s forcing lockdowns and roiling economies is spurring a silent revolution in the field of telemedici­ne.

As COVID-19 spreads across Europe, leaving new patients in its wake, the fear of infection and a saturated healthcare system are driving large numbers of people online for medical consultati­ons. Startups like General Atlantic-backed Doctolib and insurer Axa SA-supported Qare in France, Swedish Kry Internatio­nal AB’s unit Livi, the UK’s Push Doctor and Germany’s Compugroup Medical SE that offer up virtual doctors are raking it in.

“It’s unfortunat­e, but the current epidemic is pushing patients to make the leap, and it can accelerate a change in habits,” said Olivier Thierry, chief executive officer of Qare, a French platform that offers video consultati­ons with its team of doctors. “Forecasts on growth are changing by the day.”

The business of connecting doctors and patients through video consultati­ons has had a slow start in Europe because of patient reticence, an unfriendly regulatory environmen­t, disparitie­s in healthcare systems and insurance rules. Now, with hospitals struggling to cope with the virus, patients are turning to such services and government­s are setting aside reservatio­ns about the risks of “couch consultati­ons” to ease regulation­s.

The European Commission in 2018 estimated that the global telemedici­ne market would reach 37 billion euros ($42 billion) by 2021, with an annual growth rate of 14%. Those numbers may now be surpassed as virus concerns boost demand, making such consultati­ons more routine and widely accepted.

Qare’s CEO sees telemedici­ne representi­ng about 10% of France’s 400 million annual medical consultati­ons by the end of 2021 from negligible numbers now. Qare, which takes a 20% fee for consultati­ons, said that in the past couple of weeks it added 25% more bookings than usual. Last year, it had 80,000 appointmen­ts, up from 8,000 in its first full year of operation in 2018.

For Sweden’s Kry, consultati­ons for virus-related infections — like colds, flu, cough and fever — and other general demands has jumped 41% week-on-week in markets outside its home base, Johannes Schildt, its co-founder said. The startup, which raised 140 million euros in January from the Ontario Teachers’ Pension Plan, also operates in Norway, the UK, Germany and France.

The jump came “as healthcare systems in our core markets struggle to cope with the Coronaviru­s-related strain,” he said.

Doctolib, the top French start-up helping set up medical appointmen­ts, says it saw a 40% increase in bookings last week. It clocked up 130,000 video consultati­ons in its first year in that business last year.

The start-ups that manage to broaden their customer base during the virus crisis will find themselves in an increasing­ly crowded race.

In France alone, the market is spread between Qare, Livi, Mesdocteur­s, HelloConsu­lt, Medaviz, Hellocare, DoctoConsu­lt and Doctolib. In the UK the business is shared by Babylon Health, which got funding from Saudi Arabia’s Public Investment Fund, Push Doctor, askmyGP and Livi.

The current epidemic will show which players are “equipped, scaled and have the ability to face the crisis,” said Wais Shaifta, the CEO of Push Doctor, whose backers include Partech and Draper Venture Network. The UK company, which works with the NHS, has added 20% more consultati­ons since the start of the year, with a bump since last week. Mr. Shaifta expects the virus to push numbers even higher.

Telemedici­ne includes consultati­ons not only with general practition­ers but also in specialize­d areas such mental health, cardiology, dermatolog­y and others, depending on local regulation­s. Dutch start-up Ksyos has invested in the business in the Netherland­s, Italy and Austria, and helps patients with longterm ailments to consult doctors on a regular basis.

For all its growth, though, telemedici­ne is not without its detractors.

In April, PWC cited an American pediatric doctors’ analysis report, that “telemedici­ne may benefit patients by making care more convenient and accessible, but new data suggests it may also contribute to the over-prescribin­g of antibiotic­s by physicians who aren’t able to physically examine their patients.”

“Health care is a serious thing and reliable treatments cannot be traded for the comfort of consultati­ons from a couch,” said Jean-Paul Hamon of the French doctors’ federation. “Telemedici­ne must be used with more judgment and authoritie­s must make sure it’s not spreading into a business.” He said the coronaviru­s shouldn’t be “the excuse” to market telemedici­ne.

At the December congress of the industry group called Telemedici­ne Society, Nicolas Revel, who heads France’s state health-insurance system, said he wasn’t comfortabl­e with the rise of “patient-consumers.”

Countries like Switzerlan­d and Estonia have long used the system, initially with telephone consultati­ons. Switzerlan­d is starting to test video medicine with connected self-measuremen­t devices that patients can use in their homes.

In the Netherland­s, the government says people who want “care and support at home should be able to communicat­e with their care provider 24 hours a day via a screen.” A start-up called BeterDicht­bij, better-closer in Dutch, offers a Whatsapp-type consultati­on with doctors.

In Germany, the state has started relaxing rules on remote treatment, but the national culture around privacy and data protection remains a barriers. Doctolib, which entered the market with its appointmen­t-booking offer, has yet to try telehealth in Europe’s biggest market, while Kry’s Livi is starting to make inroads.

Government­s have been cautious about the spread of the practice, putting the brakes mainly through what they’re willing to reimburse and what is covered by health insurance. The French state, for instance, has been concerned about what it sees as the emergence of a parallel “private health-care” system.

“It’s not about our growth, but the government has put limits that don’t allow people to access telemedici­ne in some remote areas,” said Qare’s Thierry, calling such regulation­s a “straitjack­et.”

The coronaviru­s may be changing that.

French Health Minister Olivier Veran this week said the government has published a decree easing reimbursem­ent rules for patients using telemedici­ne. —

Newspapers in English

Newspapers from Philippines